33. Factors related to the mortality of COVID-19 patients in Hanoi in 2021
Main Article Content
Abstract
A retrospective cohort study was conducted using available data managed by Hanoi Center for Disease Control to describe several factors related to the mortality rate of COVID-19 patients recorded in Hanoi during the year of 2021. Survival analysis method and Cox regression modeling were employed to assess the relationship between mortality rate and various factors including: age, gender, comorbidity and COVID-19 vaccination status. The study results indicated that in 2021, Hanoi record 409 deaths among a total of 59,639 confirmed COVID-19 cases, resulting in a case fatality rate (CFR) of 0.69%. The factor of being male was not recognized as a factor increasing the risk of death, but age over 60 proved to be closely associated with the mortality of COVID-19 patients (HR = 19.64; 95%CI: 11.98 - 26.07). Having underlying medical conditions nearly doubled the risk of death (HR = 2.62; 95%CI: 1.21 - 2.30) while being fully vaccinated with two doses reduced the risk of death by 73% (HR = 0.27; 95%CI: 0.25 - 0.44).
Article Details
Keywords
COVID-19, Death, Hanoi
References
2. WHO Representative Office for Viet Nam. COVID-19 in Viet Nam Situation Report 109. Published online July 6, 2023. Accessed November 25, 2023. https://www.who.int/vietna m/internal-publications-detail/covid-19-in-viet-n am-situation-report-109
3. Biswas M, Rahaman S, Biswas TK, et al. Association of Sex, Age, and Comorbidities with Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis. Intervirology. 2021;64(1):36-47. doi:10.1159/000512592
4. Jutzeler CR, Bourguignon L, Weis CV, et al. Comorbidities, clinical signs and symptoms, laboratory findings, imaging features, treatment strategies, and outcomes in adult and pediatric patients with COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis. 2020;37:101825. doi:10.1016/j.tmaid.2020.101825
5. Li J, Huang DQ, Zou B, et al. Epidemiology of COVID-19: A systematic review and meta-analysis of clinical characteristics, risk factors, and outcomes. J Med Virol. 2021;93(3):1449-1458. doi:10.1002/jmv.26424
6. Dessie ZG, Zewotir T. Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients. BMC Infect Dis. 2021;21(1):855. doi:10.1186/s12879-021-06536-3
7. Bộ Y tế. Quyết định 3638/QĐ-BYT 2021 Hướng dẫn tạm thời giám sát và phòng, chống Covid-19. Published online July 30, 2021. Accessed July 5, 2022. https://luatvietnam.vn/y-te/quyet-dinh-3638-qd-byt-bo-y-te-206575-d1.html
8. Bộ Y tế. Công văn 10526/BYT-KCB 2021 xét nghiệm để phát hiện người mắc COVID-19 và cho người bệnh ra viện. Published online December 12, 2021. Accessed July 8, 2022. https://luatvietnam.vn/y-te/cong-van-10526-by t-kcb-2021-xet-nghiem-de-phat-hien-nguoi-m ac-covid-19-va-cho-nguoi-benh-ra-vien-21426 7-d6.html
9. Bộ Y tế. Công văn 11042/BYT-DP 2021 điều chỉnh định nghĩa ca bệnh COVID-19. Published online December 29, 2021. Accessed July 8, 2022. https://luatvietnam.vn/y-te/cong-v an-11042-byt-dp-2021-dieu-chinh-dinh-nghia-c a-benh-covid-19-214917-d6.html
10. Mathieu E, Ritchie H, Rodés-Guirao L, et al. Coronavirus Pandemic (COVID-19). Our World Data. Published online March 5, 2020. Accessed November 1, 2023. https://ourworldindata.org/mortality-risk-covid
11. Trang thông tin điện tử của Đảng bộ Thành phố Hồ Chí Minh. Công tác phòng chống dịch Covid-19 tại TPHCM đạt kết quả tích cực. Trang tin Điện tử Đảng bộ thành phố Hồ Chí Minh. Accessed November 1, 2023. http://www.thanhuytphcm.vn/tin-tuc/cong-tac-phong-chong-dich-covid-19-tai-tphcm-dat-ket-qua-tich-cuc-1491889186
12. Báo điện tử VOV. 4 đợt giãn cách để đưa Thủ đô Hà Nội sang giai đoạn bình thường mới. VOV.VN. Published September 19, 2021. Accessed October 27, 2023. https://vov.vn/xa-hoi/4-dot-gian-cach-de-dua-thu-do-ha-noi-sang-giai-doan-binh-thuong-moi-891853.vov
13. Berenguer J, Ryan P, Rodríguez-Baño J, et al. Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain. Clin Microbiol Infect. 2020;26(11):1525-1536. doi:10.1016/j.cmi.2020.07.024
14. Do TV, Manabe T, Vu GV, et al. Clinical characteristics and mortality risk among critically ill patients with COVID-19 owing to the B.1.617.2 (Delta) variant in Vietnam: A retrospective observational study. PLOS ONE. 2023;18(1):e0279713. doi:10.1371/journal.pone.0279713
15. Dien TC, Van Nam L, Thach PN, et al. COVID-19 patients hospitalized after the fourth wave of the pandemic period in Vietnam: Clinical, laboratory, therapeutic features, and clinical outcomes. J Formos Med Assoc. 2023;23:S0929-6646. Published online August 12, 2023. doi:10.1016/j.jfma.2023.07.020
16. Đỗ Văn Trang, Đỗ Hà Ngọc Trâm, Nguyễn Thị Thắm, và cs. Tỉ lệ tử vong và đặc điểm các trường hợp tử vong ở bệnh nhân COVID-19 được điều trị tại Bệnh viện dã chiến-3 Bình Dương. Vietnam Med J. 2022;519(2). doi:10.51298/vmj.v519i2.3668
17. Muthukrishnan J, Vardhan V, Mangalesh S, et al. Vaccination status and COVID-19 related mortality: A hospital based cross sectional study. Med J Armed Forces India. 2021;77:S278-S282. doi:10.1016/j.mjafi.2021. 06.034
18. Pormohammad A, Zarei M, Ghorbani S, et al. Effectiveness of COVID-19 Vaccines against Delta (B.1.617.2) Variant: A Systematic Review and Meta-Analysis of Clinical Studies. Vaccines. 2022;10(1):23. doi:10.3390/vaccines 10010023
19. Mohammed I, Nauman A, Paul P, et al. The efficacy and effectiveness of the COVID-19 vaccines in reducing infection, severity, hospitalization, and mortality: a systematic review. Hum Vaccines Immunother. 2022;18(1):2027160. doi:10.1080/21645515.2022.2027160
20. Hayawi K, Shahriar S, Serhani MA, et al. Vaccine versus Variants (3Vs): Are the COVID-19 Vaccines Effective against the Variants? A Systematic Review. Vaccines. 2021;9(11):1305. doi:10.3390/vaccines9111305